Patents by Inventor Sujit Kumar Basu

Sujit Kumar Basu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phase changing formulations of nucleic acid payloads
    Patent number: 9790498
    Abstract: The present invention is based, at least in part, upon discovery of a process for identifying phase changing peptides. Such phase changing peptides are capable of enhancing in vitro and in vivo delivery of oligonucleotides (e.g., dsRNAs) in lipidic, vesicular, micellar and/or naked oligonucleotide formulations.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: October 17, 2017
    Assignee: DICERNA PHARMACEUTICALS, INC.
    Inventors: Bob Dale Brown, Sujit Kumar Basu
  • Amine cationic lipids and uses thereof
    Patent number: 9549983
    Abstract: The present invention relates to lipid compounds and uses thereof. In particular, the compounds include a class of cationic lipids having an amine moiety, such as an amino-amine or an amino-amide moiety. The lipid compounds are useful for in vivo or in vitro delivery of one or more agents (e.g., a polyanionic payload or an antisense payload, such as an RNAi agent).
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: January 24, 2017
    Assignee: Dicerna Pharmaceuticals, Inc.
    Inventors: Bob Dale Brown, Sujit Kumar Basu, David A. Schwartz, Allister Fraser
  • PHASE CHANGING FORMULATIONS OF NUCLEIC ACID PAYLOADS
    Publication number: 20160083729
    Abstract: The present invention is based, at least in part, upon discovery of a process for identifying phase changing peptides. Such phase changing peptides are capable of enhancing in vitro and in vivo delivery of oligonucleotides (e.g., dsRNAs) in lipidic, vesicular, micellar and/or naked oligonucleotide formulations.
    Type: Application
    Filed: December 2, 2015
    Publication date: March 24, 2016
    Inventors: Bob Dale Brown, Sujit Kumar Basu
  • Phase changing formulations of nucleic acid payloads
    Patent number: 9217146
    Abstract: The present invention is based, at least in part, upon discovery of a process for identifying phase changing peptides. Such phase changing peptides are capable of enhancing in vitro and in vivo delivery of oligonucleotides (e.g., dsRNAs) in lipidic, vesicular, micellar and/or naked oligonucleotide formulations.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: December 22, 2015
    Assignee: Dicerna Pharmaceuticals, Inc.
    Inventors: Bob Dale Brown, Sujit Kumar Basu
  • Amine Cationic Lipids and Uses Thereof
    Publication number: 20140371293
    Abstract: The present invention relates to lipid compounds and uses thereof. In particular, the compounds include a class of cationic lipids having an amine moiety, such as an amino-amine or an amino-amide moiety. The lipid compounds are useful for in vivo or in vitro delivery of one or more agents (e.g., a polyanionic payload or an antisense payload, such as an RNAi agent).
    Type: Application
    Filed: April 17, 2014
    Publication date: December 18, 2014
    Applicant: Dicerna Pharmaceuticals, Inc.
    Inventors: Bob Dale Brown, Sujit Kumar Basu, David A. Schwartz, Allister Fraser
  • PHASE CHANGING FORMULATIONS OF NUCLEIC ACID PAYLOADS
    Publication number: 20140179765
    Abstract: The present invention is based, at least in part, upon discovery of a process for identifying phase changing peptides. Such phase changing peptides are capable of enhancing in vitro and in vivo delivery of oligonucleotides (e.g., dsRNAs) in lipidic, vesicular, micellar and/or naked oligonucleotide formulations.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 26, 2014
    Applicant: Dicerna Pharmaceuticals, Inc.
    Inventors: Bob Dale Brown, Sujit Kumar Basu
  • COMPOSITIONS COMPRISING POLYCATION-COMPLEXED PROTEIN CRYSTALS AND METHODS OF TREATMENT USING THEM
    Publication number: 20090023629
    Abstract: The present invention relates to compositions comprising polycation-complexed protein crystals and hyaluronic acid. Advantageously, the compositions of this invention are stable, long-acting and avoid local reactions at the injection site. Compositions according to this invention include sustained-release human growth hormone compositions. Such compositions are useful for treating a subject having a disorder associated with human growth hormone deficiency or that is ameliorated by human growth hormone therapy.
    Type: Application
    Filed: December 22, 2006
    Publication date: January 22, 2009
    Applicant: ALTUS PHARMACEUTICALS INC.
    Inventors: Susan Yun Qu, Shubhang Mishra, Benjamin Paul Simeone, Sujit Kumar Basu